<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 122 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page121.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=122">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 122 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 122</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=122"><img src="../thumb/122.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Autacoids - 6.2                                                                 2020-04 / 91
       Dosage:                       Warnings and special precautions: Rout. prophylax. not recomm.  Dosage: Remov.disp.tab.gently, do not force through blister lid-
       Chemo-& radio ther.induc.N&V: Adults: 8 mg by slow IVI/IMI   where little expectat.for N&V exists, max.dly dos.of 8 mg in mod./  ding foil.
       immed.bef.ther.               sev. hepat. impairm., hypersens.to other select.5-HT 3 recept. anta-  Emetogen.chemo-& radio ther: Adults: 8 mg by slow IVI/IMI im-
       Highly emetogen.chemother: Adults: Immed. bef. ther: 8 mg   gon., subac.intest.obstruct., diab. mellit., lact.intol., safety in pregn.  med. bef.ther: OR orally 1-2 hrs. bef.treatm.follow.by 8 mg orally 12
                                                                                     st
       by slow IVI/IMI. In pts.requir. higher dos.esp.those on high dos. cis-  not est., pass. into milk of lactat.animals, safety & effic.of prevent. &   hrly. When delay./prolong.emes.expect.aft.1  24 hrs. contin. orally
       platin the follow.has prov.effect: 8 mg by slow IVI/IMI immed. bef.  treatm.in elderly not est., limit.info.in sev. ren.impairm., mod.to sev.  with 8 mg 2xdly upto 5 days aft. treatm.
       chemother.,follow.by 2 further IVI/IMI dos.of 8 mg 2-4 hrs apart/by   hepat.impairm., emetogen. potent.of Ca ther.varies accord.to chemo-/   Highly emetogen.chemother: Adults: Immed. bef. ther.: Sngl.dos.
       const.infus. of 1 mg/hr for up to 24 hrs. OR sngl.dos.of 32 mg dil.in   radiother.dos.& combin.regim.  of 8 mg by slow IVI/IMI. In pts. requir.higher dos.esp.those on high
       50-100 ml saline/other compat. infus.over not less than 15 mins.im-  ONDANSETRON FRESENIUS, Fresenius Kabi [P/S]  dos. cisplatin admin.8 mg by slow IVI/IMI immed.bef. chemother, fol-
       med.bef.chemother. Effic. may be enhanc.by a sngl.IV dos.of dexa-  Ondansetron hydrochlor.dihydrate.  low.by 2 further IVI/IMI dos.of 8 mg 2-4 hrs apart/by const.infus.of
       methasone phosph.20 mg 30-45 mins.prior to 1st Mylan Ondansetron   Indications: Cytotox.chemother.& radiother. induc.N&V, prev.&   1 mg/hr x24 hrs.OR sngl.dos.of 16 mg dil.in 50-100 ml saline infus.
       dos.prior to chemother. Childr.over 4 yrs: 5 mg/m  IV over 15 mins.  treatm.of postop N&V.  over not less than 15 mins.immed. bef. chemother. Effic.may be en-
                            2
       immed.bef.chemother.          (S4) SOL.FOR INJ, 43/5.10/0542, 0543. 2 mg/ml.  hanc.by a sngl.IV dos. of dexamethasone phosph.20 mg 30-45 mins.
       Prevent.& treatm.of post-op N&V: Adults: Immed. prior to induct./  718557-001: 5x2 ml amps, R47,64  prior to 1st Vomiz dos.prior to chemother. To protect against delay./
                                                                           st
       post-op: 4 mg undil.IV.or IM. Admin.IV dos.in not less than 30 seconds,   718558-001: 5x4 ml amps, R95,29  prolong. emesis aft.1  24 hrs.contin.orally with 8 mg 2xdly upto 5
                                                                                    2
       pref. over 2-5 mins. Rep.dos.for pts.contin.to exper. N&V post-op not   Dosage: Admin.via IV inj./IV infus.aft.dilut. Emetogen. potent.of Ca   days aft.treatm. Childr.over 4 yrs: 5 mg/m  IV over 15 mins.immed.
       studied. Childr.2 yrs & over: 0,1 mg/kg up to max.4 mg by slow IV   treatm.varies accord.to dos. & combin.of chemo-/radiother.regim.used.  bef.chemother. follow. by oral ther.of 4 mg 12 hrly for upto 5 days.
       inj. prior to, at/aft. induct.of anaesthes. Treatm.of est.post-op N&V:   Emetog.chemo-& radio ther.: Adults: 8 mg as slow IV inj. im-  Prevent.& treatm.of post-op N&V: Rout. prophylax. not recomm.
       Admin. 0,1 mg/kg upto max. 4 mg by slow IVI. Rep.dos.in childr.  med.bef.ther.  where expect.incid.of N&V low. Childr.2 yrs & over: 0,1 mg/kg up
       who contin.to exp.N&V not studied, theref.should not to be given.  Highly emetogen.chemother: Immed.bef.ther: 8 mg as sngl.dos.by   to max.4 mg by slow IV inj.prior to, at/aft.induct.of anaesthes. Rep.
       Contraindications: Pregn.for post-op N&V, lactat.  slow IV inj. In pts.requir. higher dos.esp.those on high dos.cisplatin the   dos.for pts.contin.to exper.N&V post-op not stud.
       Side effects: Headache, seiz., arrythm., hypotens., bradycard., chest   follow. has prov.effect: 8 mg by slow IV inj. immed. bef.chemother.,   Adults. Immed.prior to induct./post-op: 4 mg undil. IV.or IM. Ad-
       pain, constip., hypersens. reacts.incl.anaphylax., invol. movem. disor-  foll.by 2 furth.dos.of 8 mg 2-4 hrs apart/by const.infus.of 1 mg/hr for   min.IV dose in not less than 30 seconds, pref.over 2-5 mins. Alter-
       ds., loc.reacts.follow.inj., flush., hiccups, trans. vis.disturbs.  up to 24 hrs. OR sngl.dos.of 32 mg dil.in 50-100 ml saline or other   nat.16 mg orally 1 hr.prior to anaesthes.induct. Rep.dos.for pts. contin.
       Special precautions: Rout.prophylax.not recomm. where expectat.  compat.fluid infus.over not less than 15 mins. immed.bef.chemother.   to exper.N&V post-op not stud.
       of N&V small, tot. dly dos.of 8 mg not to be exceed.in mod./sev.hepat.   Effic.may be enhanc. by add.sngl.IV dos.of dexamethasone phosph.   Treatm.of est.post-op N&V: Childr. 2 yrs & old: 0,1 mg/kg upto
       impairm., safety & effic.not est.in treatm.of post-op N&V in elderly,   20 mg 30-45 mins.prior to 1st Ondansetron Fresenius dos. prior to   max.4 mg by slow IVI. Rep. dos. in childr.who contin.to exp.N&V not
       few pts.above 80 kg or below 40 kg have been stud., do not admin.  chemother. Childr. over 4 yrs: 5 mg/m  IV over 15 mins. immed. bef.  studied, theref. should not to be given.
                                                     2
       in same syringe/ infus.as other medicat., do not autoclav., hypersens.  chemother. Treatm.to be contin.with oral ondansetron.  Contraindications: Granisetron/dolasetron sensitiv., concom.apo-
       report.when hypersens.to other select. 5-HT3 recept.antagon.report.,   Prevent.& treatm.of post-op N&V: Adults: Immed. prior to induct./  morphine, congenit.long QT syndr., pregn.
       monit.pts.with subac. intest.obstruct.  post-op: Admin.4 mg undil. IV in not less than 30 seconds, pref.over   Side effects: Freq: Headache, trans.vis. disturbs. aft.rapid IV admin.,
                                                                  incr.large bowel transit time, constipat., diarrh., fev., cold sensat.
       NAUSETRON, (Aspen Pharmacare: Pharma) Brimpharm [P/S]  2-5 mins. Rep. dos.for pts.contin.to exper &/ V post-op not stud. Chil-  Less freq: Seiz., dizzin., invol.movem.disords., drowsin., paraesthes.,
                                     dr. 2 yrs & old: 0,1 mg/kg up to max. 4 mg by slow IV inj. prior to, at/
       Ondansetron as hydrochlor.dihydrate.  aft.induct.of anaesthes. Treatm.of est.post-op N&V: Admin. 0,1 mg/  dysrhythm., hypotens., bradycard. & chest pain with/-out ST segm
       Indications: Cytotox.chemother.& radiother. induc. N&V, prevent.&   kg up to max.4 mg by slow IV inj. Rep. dos. in childr. who contin.to   depress., QT prolongat.incl.torsades de pointes, abdom.pain, stom-
       treatm.of postop N&V.         exp.N&V not studied, theref. should not to be giv.  ach cramps, dry mouth, asymptomat. aminotransferas.incr., loc.inj.
       (S4) INJ, A39/5.10/0462, 0463. 2 mg/ml.  Refer to prod.lit.for compat.with IV fluids/other meds.  site reacts., warmth sensat./flush., hiccups, trans. unusual tiredn./
       705078-001: 5x2 ml amps, R50,81  Contraindications: Safety in pregn.not est., lactat., congen.long   weakn. Freq.unknown: Trans. blindn., tachycard., bradycard., car-
       705079-001: 5x4 ml amps, R97,22  QT syndr., concom. apomorphine, limit.data avail.on sev.imp.ren.   diopulm.arrest, ECG alterat., palpitat., syncope, trans.rise in liv. en-
       Dosage: Emetogen.chemo-& radio ther: Adults: 8 mg by slow   funct., do not admin.in same syr./infus.as other medicat., amps.   zym., skin rash, urticar., prurit.
       IVI/IMI immed.bef.ther.       not to be autoclav.          Warnings and special precautions: Rout. post-op N&V prophy-
       Highly emetogen.chemother: Adults: Immed. bef.therapy: 8 mg   Side effects: Trans.ECG chang.incl.QT interv. prolong./Torsade de   lax.not recomm.where expectat.low, condit.for poss.develop,of QT
       by slow IVI/IMI In pts.requir. higher dos.esp.those on high dos. cis-  Point., immed.hypersens. reacts. somet.sev.incl.anaphylax., CNS   prolongat., mod.to sev.hepat.impairm.with tot. dly.dos. of 8 mg not
       platin the follow.has prov.effect: 8 mg by slow IVI/IMI immed. bef.  effs., headache, extrapyramid./loc.reacts., seiz., dizzin. dur. rapid   to be exceed., passes into breast milk, safety & effic.of post-op N&V
       chemother,follow.by 2 further IVI/IMI dos. of 8 mg 2-4 hrs apart/by   infus., trans.vis.disturbs., dysrhythm., chest pain with/-out ST segm.  treatm./prophylax.in elderly not est., limit.info.for sev.ren.impairm.,
       const.infus.of 1 mg/hr x24 hrs.OR sngl.dos.of 32 mg dil.in 50-100 ml   depress., bradycard., flush., hypotens., hiccups, constip., incr.large   do not admin.in same syringe/ infus.as other medicat., do not auto-
       saline infus.over not less than 15 mins. immed.bef.chemother. Effic.  bowel transit time, incr.LFT.  clav.amps.,  pts.exhibit.hypersens.reacts.to other select. 5-HT 3 recept.
       may be enhanc.by a sngl.IV dos.of dexamethasone phosph. 20 mg 30-  Special precautions: Rout.prophylax.not recomm. where expect.  antagon., monit.subac.intest. obstruct. pts., lact.intol., phenylketonur.
       45 mins.prior to 1st Nausetron dos.prior to chemother. Protect.against   of N&V small, pass.into milk of lactat.animals, tot.dly.dos.of 8 mg   Interactions: Addit.QT prolongat.with meds. lead.to QT interv.pro-
       delay.emesis aft.1st 24 hrs: 8 mg orally 2xdly x5 days aft.course.   not to be exceed. in mod./sev.hepat.impairm., those hav./ poss. de-  longat., incr.dysrhythm.risk with cardiotox.agents eg anthracycl., hypo-
       Childr. over 4 yrs: 5 mg/m  IV over 15 mins. immed.bef.chemother.  vel.QTc prolong.incl.condits./meds.caus. QT prolong./electr.abnorm.,   tens.& loss of conscious.with apomorph., rifampicin/ carbamazepine
                  2
       Prevent.& treatm.of post-op N&V: Adults. Immed. prior to induct./  hypersens.report. when hypersens.to other select.5-HT3 recept. an-  or phenytoin reduc.plasma conc., analages.effic.of tramadol reduc.
       post-op: 4 mg undil.IV.or IM. Admin.IV dos.in not less than 30 seconds,   tagon., monit.pts.with subac.intest.obstruct., few pts. above 80 kg or   ZOFER, Ranbaxy P/S]
       pref. over 2-5 mins. Rep.dos.for pts.contin.to exper. N&V post-op not   below 40 kg have been stud., limit. exper.in post-op N&V prevent.&   Ondansetron HCl
       studied. Childr.2 yrs & over: 0,1 mg/kg up to max. 4 mg by slow IV   treatm. use in elderly.  Indications: N&V induc.by chemo-& radiother., prev.& treatm.
       inj. prior to, at/aft.induct.of anaesthes. Treatm.of est.post-op N&V:   Drug interactions: Reduc.bld.conc.with phenytoin/ carbamazepine/  of postop N&V.
       Admin.0,1 mg/kg up to max. 4 mg by slow IVI. Rep.dos.in childr.who   rifampicin, analges. eff.of tramadol poss.reduc., hypotens./ loss of   (S4) INJ, 39/5.10/0448, 0449. 2 mg/ml.
       contin.to exp.N&V not studied,theref.not to be given.  consciousn./ poss.intens.QT prolong.with apomorphine  705941-001: 4 mg/2 ml, 5x2 ml amps, R40,24
       Contraindications: Lactat., pregn., post-op N&V            705943-001: 8 mg/4 ml, 5x4 ml amps, R279,85
       Side effects: Headache, seiz., arrhythm., hypotens., bradycard.,   ONICIT, Pfizer [P/S] &  (S4) TABS, 39/5.10/0413, 0414.
       chest pain, constip., hypersens. reacts.incl.anaphylax., invol.movem.   Palonosetron hydrochlor.  705944-001: 4 mg, 10, R164,89
       disords., loc.reacts.follow.inj., flush., hiccups, trans.vis.disturbs.  Indications: Prev.of ac.N&V assoc.with mod.to high.emetogen.  705945-001: 8 mg, 10, R329,81
       Special precautions: Rout.prophylax.not recomm. where expec-  Ca chemother.  (S4) RAPITABS, 42/5.10/0662, 0663
                                     (S4) SOL.FOR INJ, A40/5.10/0322. 50 µg/ml
       tat.of N&V small, tot.dly dos. of 8 mg not to be exceed.in mod./sev.  713980-001: 4 mg, 10, R342,77
       hepat. impairm., safety & effic.not est.in treatm.of post-op N&V in   708388-001: sngl.5 ml vial, R642,27  714957-001: 8 mg, 10, R685,46
                                     Dosage: Rep.dos.within 7 days not recomm. Effic. may be enhanc.
       elderly, do not admin.in same syringe/ infus. as other medicat., monit.  Dosage: Emetogen.pot.of Ca treatm.varies accord.dos.& combi-
       pts.with subac. intest. obstruct., hypersens.react.in pts. hypersens. to   by addit.of corticoster.admin.prior to chemother.  nat.of chemo./radiother. regim.used. Allow rapitab to dissolv.on
                                     Adults: 250 µg as sngl.IV bolus admin.over 30 secs. approx.30 mins
       other 5-HT 3 recept.antagon.  bef.start of chemother.      tong.& then swallow.
       ONDANSETRON CIPLA, Cipla-Medpro [P/S]  Contraindications: Pregn., not recomm.in pts. und.18 yrs.  Emetogen.chemo-& radio ther: Adults: 8 mg by slow IVI/IMI im-
                                                                  med.bef.ther: OR orally 1-2 hrs.bef.treatm.follow.by 8 mg orally 12
       Ondansetron as hydrochlor.dihydrate.  Side effects: Headache, constipat., diarrh., hyperkalaem., metabol.  hrly. When delay./prolong.emes.expect.aft.1  24 hrs. contin.orally
                                                                                     st
       Indications: Chemother.& radiother.induc.N&V, prevent. & treatm.  disords., hypocalcaem., anorex., hyperglycaem., decr.appetite, anx.,   with 8 mg 2xdly upto 5 days aft. treatm.
       of postop N&V.                euphor.mood, CNS effs., eye irrit., amblyop., mot.sickn., tinnit., ar-  Highly emetogen.chemother: Adults: Immed. bef.ther.: Sngl.dos.
       (S4) TABS, A38/5.10/0435, 0436  rythm., myocard.ischaem., hypo-/hypertens., vein discolourat./dist-  of 8 mg by slow IVI/IMI. In pts.requir.higher dos.esp.those on high dos.
       716801-001: 4 mg, 10, R188,22  ent., hiccups. GI disords., hyperbilirubinaem., allerg. dermatit., prurit.  cisplatin the follow.has prov.effect: 8 mg by slow IVI/IMI immed.bef.
       716802-001: 8 mg, 10, R376,44  rash, arthralg., urin.retent., glycosur., asthen., pyrex., fatig., influ-like   chemother, follow.by 2 further IVI/IMI dos.of 8 mg 2-4 hrs apart/by
       Dosage: Naus.& vomit.induc.by chemo-& radio ther:  illn., elev.transamin., hypokalaem., electrocardiogram QT prolongat.,   const.infus.of 1 mg/hr x24 hrs.OR sngl.dos.of 32 mg dil.in 50-100 ml
       Emetogen.chemother.& radiother: Adults: Most pts: 8 mg slow   hypersens.reacts., inj.site reacts.  saline infus.over not less than 15 mins.immed.bef.chemother. Effic.
       IV/IM inj.immed.prior to treatm. or oral. 1-2 hrs.bef.treatm.follow.by   Special precautions: Discont.breast feed.prior to ther., constip.,   may be enhanc.by a sngl.IV dos.of dexamethasone phosph.20 mg 30-
       8 mg oral.12 hrly. Where delay./prolong.emesis expect. aft 1st 24 hrs.  sub-ac.intestin.obstruct., meds that incr.QT interv., where prolong.  45 mins.prior to 1st Zofer dos. prior to chemother. To protect against
       admin.8 mg orally 2xdly.for up to 5 days follow.treatm.  QT interv.exists/is poss., no data avail.in end stage ren.dis.under-  delay./ prolong.emesis aft.1  24 hrs.contin.orally with 8 mg 2xdly upto
                                                                              st
       Highly emetogen.chemotherapy: Adults: Admin. IV. Tab.effic.may   go. haemodialys.  5 days aft.treatm. Childr.over 4 yrs: 5 mg/m  IV over 15 mins.immed.
                                                                                    2
       be enhanc.by addit.of sngl. IV dos.of dexamethasone phosph.20 mg   See also MDR page 628.  bef. chemother.follow.by oral ther.of 4 mg 12 hrly for upto 5 days.
       admin. 30-45 mins.bef.first oral dos.prior to chemother. Protect.  VOMIZ, Zydus [P/S]  Prevent.& treatm.of post-op N&V: Rout. prophylax.not recomm.
       against delay.emesis aft.1st 24 hrs: 8 mg oral.2x/day for up to 5   Ondansetron  where expect.incid.of N&V slight. Childr. 2 yrs & over: 0,1 mg/kg up
       days aft. treatm. course.     Indications: N&V induc.by chemo-& radiother., prev. & treatm.  to max.4 mg by slow IV inj.prior to, at/aft.induct. of anaesthes. Adults.
       Childr.over 4 yrs: Exper.limit.but prov.effect.& well tol. Admin.IV at   of postop N&V.  Immed.prior to induct./ post-op: 4 mg undil.IV.or IM. Admin.IV dose in
       dos.of 5 mg/m  over 15 mins. immed.bef.chemother.follow.by 4 mg   (S4) INJ, A39/5.10/0581, 0582. 4 mg/2 ml.  not less than 30 seconds, pref.over 2-5 mins. Alternat.16 mg orally
             2
       orally 12 hrly.for up to 5 days.  716548-001: 5x2 ml amps, R44,18  1 hr.prior to anaesthes. induct. Rep.dos.for pts.contin.to exper.N&V
       Prevent.& treatm.of post-op N&V: Adults: 16 mg oral.1 hr bef.an-  711533-001: 5x5 ml amps, R84,15  post-op not studied.
       aesthes.induct. Rep.dos. for contin.post-op N&/V not stud.  (S4) TABS, 42/5.10/0109, 0110  Treatm.of est.post-op N&V: Childr. 2 yrs & over: 0,1 mg/kg upto
       Contraindications: Post-op N&V in pregn.  711531-001: 4 mg, 10, R172,35  max.4 mg by slow IVI. Rep. dos.in childr.who contin.to exp.N&V not
       Side effects: Freq: Headache, warm/flush. sensat., constip. Less   711532-001: 8 mg, 10, R344,74  studied, theref.should not to be given.
       freq: Immed.hypersens. reacts. incl.anaphylax., seiz., extrapyramid.   (S4) DISP.TABS, 42/5.10/0577, 0578  Contraindications: Safety in pregn.not est., lactat.
       reacts. incl.oculogyr.crisis & dyston.reacts., arrhythm., bradycard.,   3000044-001: 4 mg, 10, R358,28  Side effects: Headache, seiz., arrythm., hypotens., bradycard., chest
       chest pain, hypotens., hiccups, incr.LFT, invol.movem.disords.  3000045-001: 8 mg, 10, R716,50  pain, constip., hypersens. reacts.incl.anaphylax., invol.movem. disor-</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page121.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page117.html">117</a>&nbsp;&nbsp;&nbsp;<a href="page118.html">118</a>&nbsp;&nbsp;&nbsp;<a href="page119.html">119</a>&nbsp;&nbsp;&nbsp;<a href="page120.html">120</a>&nbsp;&nbsp;&nbsp;<a href="page121.html">121</a>&nbsp;&nbsp;&nbsp;<a href="page122.html">122</a>&nbsp;&nbsp;&nbsp;<a href="page123.html">123</a>&nbsp;&nbsp;&nbsp;<a href="page124.html">124</a>&nbsp;&nbsp;&nbsp;<a href="page125.html">125</a>&nbsp;&nbsp;&nbsp;<a href="page126.html">126</a>&nbsp;&nbsp;&nbsp;<a href="page127.html">127</a>
             </td>
             <td width="35%"><a href="page123.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page123.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
